home / stock / rckt / rckt quote
Last: | $20.03 |
---|---|
Change Percent: | 1.26% |
Open: | $19.76 |
Close: | $19.78 |
High: | $20.19 |
Low: | $19.5 |
Volume: | 352,291 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$20.03 | $19.76 | $19.78 | $20.19 | $19.5 | 352,291 | 07-03-2024 |
$19.78 | $20.72 | $19.78 | $20.99 | $19.74 | 668,664 | 07-02-2024 |
$20.66 | $21.34 | $20.66 | $21.79 | $20.22 | 1,078,735 | 07-01-2024 |
$21.53 | $19 | $21.53 | $21.6 | $18.6 | 4,001,952 | 06-28-2024 |
$21.43 | $21.35 | $21.43 | $21.68 | $20.8669 | 672,295 | 06-27-2024 |
$21.29 | $23.65 | $21.29 | $23.67 | $21.27 | 908,957 | 06-26-2024 |
$23.85 | $24.07 | $23.85 | $24.55 | $23.7 | 951,925 | 06-25-2024 |
$24.06 | $22.65 | $24.06 | $24.45 | $22.61 | 1,806,914 | 06-24-2024 |
$22.48 | $21.31 | $22.48 | $22.59 | $21.267 | 3,688,537 | 06-21-2024 |
$20.85 | $20.58 | $20.85 | $21.0575 | $20.275 | 995,069 | 06-20-2024 |
$20.68 | $21.24 | $20.68 | $21.24 | $20.52 | 543,248 | 06-19-2024 |
$20.68 | $21.24 | $20.68 | $21.24 | $20.52 | 543,248 | 06-18-2024 |
$21.2 | $21.74 | $21.2 | $21.81 | $21.02 | 662,469 | 06-17-2024 |
$21.86 | $22.54 | $21.86 | $22.61 | $21.81 | 473,383 | 06-14-2024 |
$22.86 | $22.7 | $22.86 | $23.0336 | $22.56 | 339,952 | 06-13-2024 |
$22.73 | $23.67 | $22.73 | $24.38 | $22.65 | 1,484,378 | 06-12-2024 |
$22.91 | $22.19 | $22.91 | $23.08 | $21.96 | 492,440 | 06-11-2024 |
$22.35 | $22.38 | $22.35 | $22.73 | $21.93 | 775,532 | 06-10-2024 |
$22.68 | $22.63 | $22.68 | $23.21 | $22.36 | 536,257 | 06-07-2024 |
$22.99 | $23.07 | $22.99 | $23.4 | $22.58 | 610,264 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Rocket Pharmaceuticals Inc. Company Name:
RCKT Stock Symbol:
NASDAQ Market:
Rocket Pharmaceuticals Inc. Website:
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet needs, today announced a regulatory update for KRESLADI™ (marnetegragene autotemcel; marne-cel), a le...
2024-06-02 14:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the European Commission (EC), based on a positive opinion issued by the Committ...